Scarica l'app Stockscreener
77.84
1.35%
-1.00
Dopo l'orario di chiusura:
77.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$78.84
Aprire:
$78.99
Volume 24 ore:
913.80K
Relative Volume:
1.00
Capitalizzazione di mercato:
$5.16B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
12.95
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
+2.71%
1M Prestazione:
+17.97%
6M Prestazione:
+44.51%
1 anno Prestazione:
-20.78%
Intervallo 1D:
$77.08
$80.00
Intervallo di 1 settimana:
$72.94
$80.91
Portata 52W:
$47.25
$111.29
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
77.84 | 5.23B | 1.50B | 427.61M | 423.98M | 6.01 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.96 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Aggiornamento | Truist | Hold → Buy |
| 2025-10-08 | Downgrade | Goldman | Buy → Neutral |
| 2025-08-12 | Downgrade | Truist | Buy → Hold |
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
William Blair Investment Management LLC Has $29.48 Million Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Intech Investment Management LLC Sells 33,704 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus receives FDA tentative approval for generic cancer drug By Investing.com - Investing.com Canada
Lantheus Holdings (LNTH): Analyst Raises Price Target to $89 | L - GuruFocus
Lantheus (LNTH) Secures FDA Tentative Nod for New Cancer Treatme - GuruFocus
Lantheus Says US FDA Tentatively Approves PNT2003 - marketscreener.com
FDA tentatively backs new tumor therapy similar to LUTATHERA - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 21% Upside Potential - DirectorsTalk Interviews
Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Rebound And PYLARIFY Outlook - Yahoo Finance UK
Lantheus Holdings, Inc. $LNTH Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Lantheus Holdings (LNTH) Net Margin Decline Tests Bullish Earnings Growth Narrative - Sahm
TD Asset Management Inc Increases Stock Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Dana Investment Advisors Inc. Sells 13,875 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Seaport Global Upgrades LNTH to Neutral Feb 27, 2026 Lantheus Holdings, Inc - Meyka
Lantheus (NASDAQ:LNTH) Price Target Raised to $85.00 at Mizuho - MarketBeat
LNTH: Mizuho Raises Price Target to $85, Maintains Outperform Ra - GuruFocus
Truist Securities Adjusts Lantheus Holdings PT to $89 From $82, Maintains Buy Rating - marketscreener.com
LNTH: 2025 Earnings Flash Report - Zacks Small Cap Research
Citizens Analyst Raises Lantheus Holdings (LNTH) Price Target to $85.00 | LNTH Stock News - GuruFocus
Lantheus (NASDAQ:LNTH) Given "Hold" Rating at JonesTrading - MarketBeat
Lantheus Holdings (LNTH) Downgraded to Hold by Jones Trading | L - GuruFocus
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2025 Earnings Call Transcript - Insider Monkey
Vanguard Group Inc. Raises Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Citizens raises Lantheus stock price target on strong Q4 results By Investing.com - Investing.com Canada
Decoding Lantheus Holdings Inc (LNTH): A Strategic SWOT Insight - GuruFocus
Lantheus (NASDAQ:LNTH) Releases Earnings Results - MarketBeat
William Blair Upgrades Lantheus Holdings (LNTH) to Outperform Feb 26, 2026 - Meyka
Lantheus Holdings (LNTH) Reports Revenue Growth and Strategic Sh - GuruFocus
Jones Trading downgrades Lantheus stock rating to hold on revenue outlook By Investing.com - Investing.com South Africa
Lantheus Earnings Call Maps Painful Reset Before 2027 - TipRanks
Jones Trading downgrades Lantheus stock rating to hold on revenue outlook - Investing.com
Lantheus Q4 Earnings Call Highlights - MarketBeat
Lantheus Holdings Inc (LNTH) Q4 2025 Earnings Call Highlights: N - GuruFocus
Lantheus (LNTH) Q4 2025 Earnings Call Transcript - AOL.com
Lantheus Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:LNTH) 2026-02-26 - Seeking Alpha
Lantheus (NASDAQ:LNTH) Stock Rating Upgraded by William Blair - MarketBeat
Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations - Finviz
William Blair upgrades Lantheus stock rating on product pipeline - Investing.com
Lantheus (LNTH) Given an Upgrade Amid Promising Growth Prospects - GuruFocus
Lantheus Q4 2025 slides: earnings beat masks flagship product decline - Investing.com Australia
Lantheus’s 2026 Revenue Guidance Amid Expected Q4 Decline Might Change The Case For Investing In LNTH - simplywall.st
Lantheus Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Lantheus Holdings Inc earnings beat by $0.51, revenue topped estimates - Investing.com South Africa
Earnings call transcript: Lantheus Holdings Inc Q4 2025 beats forecasts but faces market dip - Investing.com
Lantheus Q4 2025 slides: earnings beat masks flagship product decline By Investing.com - Investing.com Canada
Lantheus Q4 Adjusted Earnings, Revenue Rise; Sets 2026 Guidance - marketscreener.com
Lantheus Holdings: Fourth Quarter Earnings Overview - Bitget
Lantheus (NASDAQ:LNTH) Releases FY 2026 Earnings Guidance - MarketBeat
Lantheus Holdings, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com
Tranche Update on Lantheus Holdings, Inc.'s Equity Buyback Plan announced on August 6, 2025. - marketscreener.com
Lantheus (LNTH) Revises Revenue Forecast Below Market Expectatio - GuruFocus
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.18%
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):